Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABSI Absci Corporation.

Pre-Mkt 06-26 05:25:02 EDT

10.21

+0.14

+1.34%

盘前9.95

-0.26-2.55%

05:24 EDT

High11.25	Low9.32	Vol13.22M
Open11.00	D1 Closing10.08	Amplitude19.16%
Mkt Cap1.59B	Tradable Cap1.49B	Total Shares155.45M
T/O133.83M	T/O Rate9.06%	Tradable Shares146.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABSI","market":"US","secType":"STK","nameCN":"Absci Corporation.","latestPrice":10.21,"timestamp":1782417600000,"preClose":10.075,"halted":0,"volume":13221544,"hourTrading":{"tag":"盘前","latestPrice":9.95,"preClose":10.21,"latestTime":"05:24 EDT","volume":8029,"amount":80313.468767,"timestamp":1782465879261,"change":-0.26,"changeRate":-0.025465,"amplitude":0.032801},"delay":0,"changeRate":0.013399503722084522,"floatShares":146000000,"shares":155447428,"eps":-0.823032,"marketStatus":"Pre-Mkt","change":0.135,"latestTime":"06-26 05:25:02 EDT","open":11,"high":11.2499,"low":9.32,"amount":133832104.2926,"amplitude":0.191553,"askPrice":9.98,"askSize":50,"bidPrice":9.5,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.823032,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782480600000},"marketStatusCode":1,"adr":0,"listingDate":1626926400000,"exchange":"NASDAQ","adjPreClose":10.21,"preHourTrading":{"tag":"盘前","latestPrice":9.95,"preClose":10.21,"latestTime":"05:24 EDT","volume":8029,"amount":80313.468767,"timestamp":1782465879261,"change":-0.26,"changeRate":-0.025465,"amplitude":0.032801},"postHourTrading":{"tag":"盘后","latestPrice":10.35,"preClose":10.21,"latestTime":"19:58 EDT","volume":43119,"amount":440573.0859,"timestamp":1782431926718,"change":0.14,"changeRate":0.013712,"amplitude":0.024368},"volumeRatio":0.9808162723370532,"impliedVol":1.2243,"impliedVolPercentile":0.728},"requestUrl":"/m/hq/s/ABSI/","defaultTab":"news","newsList":[{"id":"2646874792","title":"Absci price target raised to $10 from $4.10 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874792?lang=en_us&edition=fundamental","pubTime":"2026-06-25 18:50","pubTimestamp":1782384647,"startTime":"0","endTime":"0","summary":"Morgan Stanley raised the firm’s price target on Absci (ABSI) to $10 from $4.10 and keeps an Equal Weight rating on the shares after the company re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-price-target-raised-to-10-from-4-10-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-price-target-raised-to-10-from-4-10-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","ABSI","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646826865","title":"Absci (ABSI) Is Up 40.3% After Positive ABS-201 Data And Equity Raise Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2646826865","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646826865?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:16","pubTimestamp":1782353811,"startTime":"0","endTime":"0","summary":"Earlier this week, Absci Corporation reported encouraging interim Phase 1 data for ABS-201 in androgenetic alopecia, showing a favorable safety profile across single ascending IV dose cohorts and an estimated half-life of at least 65 days, while also completing a US$100,000,003 follow-on equity offering of 13,495,277 common shares at US$7.41.\nThe early indication that ABS-201 might be dosed only two or three times over six months, combined with fresh funding to advance trials and pursue...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-is-up-403-after-positive-abs-201-data-and-equity","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-absi/absci/news/absci-absi-is-up-403-after-positive-abs-201-data-and-equity","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","BK4585","BK4215","BK4139","BK4539","ABSI","EQR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646684841","title":"Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2646684841","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646684841?lang=en_us&edition=fundamental","pubTime":"2026-06-25 03:02","pubTimestamp":1782327725,"startTime":"0","endTime":"0","summary":"Absci's  ABS-201 showed a favorable early safety profile, with no serious adverse events, and pharmacokinetic data supporting a potential two- to three-injection regimen over six months, Truist said in a note on Wednesday.ABS-201 is an anti-prolactin receptor antibody being developed for the treatment of androgenetic alopecia.Truist said the interim phase 1 results represent a de-risking event for the program and that it is now looking ahead to proof-of-concept efficacy data expected in H2.The convenience of that dosing schedule, if supported by future efficacy readouts, could position ABS-201 as a preferred option in the hair growth space, the note said.Truist kept its Buy rating and $11 price target on the stock.Shares of Absci surged 35% in Wednesday afternoon trading.Price: 10.02, Change: +2.61, Percent Change: +35.22","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABSI","BK4539","BK4139","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646284834","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD) and AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646284834","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646284834?lang=en_us&edition=fundamental","pubTime":"2026-06-25 02:40","pubTimestamp":1782326412,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD) and AbSci (ABSI). InMode (INMD) In a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-and-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-and-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LU0128526141.USD","HCSG","BK4581","XBI","BK4588","INMD","BK4139","LABU","BK4082","BK4585","XLV","ABSI","BK4539","BK4137","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646313848","title":"Analysts Are Bullish on These Healthcare Stocks: Inmune Bio (INMB), AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2646313848","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646313848?lang=en_us&edition=fundamental","pubTime":"2026-06-25 02:30","pubTimestamp":1782325817,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inmune Bio (INMB), AbSci (ABSI) and Ionis Pharmaceut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inmune-bio-inmb-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inmune-bio-inmb-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","INMB","ABSI","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646757817","title":"Absci is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2646757817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646757817?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:36","pubTimestamp":1782322560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings(END) Dow Jones NewswiresJune 24, 2026 13:36 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4121","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646581729","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2646581729","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646581729?lang=en_us&edition=fundamental","pubTime":"2026-06-25 01:31","pubTimestamp":1782322260,"startTime":"0","endTime":"0","summary":"Pulsenmore  said Wednesday it is partnering with Ouma Health to expand access to remote prenatal care in the US.Shares soared 160% as intraday trading volume catapulted to over 48.6 million from a daily average of about 18,000.Absci  said it has priced its underwritten offering of about 13.5 million shares at $7.41 each to raise about $100 million. The offering includes participation from Eli Lilly .Shares surged 35% amid a jump in intraday trading volume to over 26.4 million from a daily average of almost 5 million.Agility Robotics is set to go public via a merger with blank check firm Churchill Capital XI  in a deal valuing the robot maker at $2.5 billion, the companies said Wednesday.Shares jumped 17% following a rise in intraday trading volume to over 11.3 million from a daily average of about 22,000.Price: 9.02, Change: +5.61, Percent Change: +164.52","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999015986.USD","LU0198837287.USD","LU0456855351.SGD","PLSM","LU2112291526.USD","SG9999018857.SGD","LU2237443622.USD","LU1267930730.SGD","LU0708995401.HKD","LU0353189680.USD","BK4599","LU0289739699.SGD","LU0385154629.USD","LU0882574055.USD","LU1064131342.USD","LU1868837300.USD","LU2271345857.HKD","LU2360106947.USD","IE0001KFT4U8.USD","LU2491050071.SGD","IE0004445015.USD","LU0471298694.HKD","LU1145028129.USD","LU2471134952.CNY","LU2552382215.SGD","LU0417517546.SGD","LU2087625088.SGD","LU2111349929.HKD","IE00B1XK9C88.USD","LU0471298777.SGD","SG9999014914.USD","LU2213496289.HKD","ELIS","LU0672654240.SGD","LU1983299246.USD","IE00B775H168.HKD","LU2089984988.USD","LU2237443895.HKD","LU0106261372.USD","IE00B4R5TH58.HKD","LU0266013472.USD","LU2023250504.SGD","BK4139","LU2237438978.USD","LU0820561818.USD","LU1804176565.USD","LU2237443978.SGD","BK4082","IE00B7KXQ091.USD","BK4588","SG9999015945.SGD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU0006306889.USD","BK4516","LU2211815571.USD","LU2265009873.SGD","LU2461242641.AUD","LU2896262040.SGD","SG9999001176.USD","LU0158827948.USD","LU0964807845.USD","ELIL","LU1623119135.USD","LLY","IE00BJJMRY28.SGD","LU0466842654.USD","LU1551013342.USD","LU1057294990.SGD","LU1917777945.USD","SG9999015952.SGD","LU2028103732.USD","LU0210536198.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B4JS1V06.HKD","LU0787776722.HKD","LU1093756325.SGD","LU2552382058.USD","LU0058720904.USD","SG9999001176.SGD","LU0823416689.USD","LU0109391861.USD","ABSI","LU0820562030.AUD","LU1232071149.USD","LU0786609619.USD","LU0683600562.USD","LU1291159041.SGD","LU2491050154.USD","SG9999014880.SGD","LU0097036916.USD","LU1868837136.USD","LU2237443549.SGD","LU2237443382.USD","IE00BJLML261.HKD","LU0122379950.USD","LU1712237335.SGD","BK4581","LU0943347566.SGD","LU0882574139.USD","BK4585","LU2108987350.USD","LU2237443465.HKD","LU0689472784.USD","LU0432979614.USD","LU2089283258.USD","LU2168563687.JPY","SG9999017495.SGD","LU1548497426.USD","LU0323591593.USD","LU1551013425.SGD","IE0002141913.USD","LU1989771016.USD","BK4534","LU2168564495.EUR","IE00BKDWB100.SGD","IE00BKPKM429.USD","LU0316494557.USD","LU2264538146.SGD","LU2361044865.SGD","BK4007","LU1814569148.SGD","LU0238689110.USD","LU1061106388.HKD","LU2756315318.SGD","LU1093756168.USD","LU0823434583.USD","SGXZ81514606.USD","LLII","LU2063271972.USD","LU0114720955.EUR","LU0820561909.HKD","IE00BK4W5L77.USD","LU2750360641.GBP","LU0225283273.USD","LU0320765992.SGD","IE00BFSS8Q28.SGD","CCXI","LU2168564149.EUR","IE00BN29S564.USD","LLYZ","SGXZ99366536.SGD","IE00BK4W5M84.HKD","IE0009355771.USD","LU0234572021.USD","LU2491049909.HKD","LU1868836914.USD","LU2471134523.USD","LU2456880835.USD","LU2746668461.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU0203202063.USD","LU1868836757.USD","LU2462157665.USD","LU1127390331.HKD","SG9999018865.SGD","LU2023251221.USD","LU0354030438.USD","LU0256863902.USD","LU0094547139.USD","BK4121","LU2236285917.USD","LU0640476718.USD","LU0823434740.USD","LU0889565916.HKD","LU0203201768.USD","LU2106854487.HKD","SG9999015978.USD","LU2552382132.HKD","LU2361044949.HKD","LU2168564222.USD","LU2468319806.SGD","SG9999014898.SGD","LU2471134796.USD","LU0353189763.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU1023059063.AUD","LU2089284900.SGD","LU0096364046.USD","LU0133085943.USD","LU0061475181.USD","LU1366192091.USD","IE0005OL40V9.USD","LU1868836591.USD","LU2471134879.HKD","LU2746668974.SGD","BK4533","LU2168564065.EUR","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1280957306.USD","IE00BJT1NW94.SGD","LU0079474960.USD","LU0354030511.USD","LU2357305700.SGD","IE0004445239.USD","LU0256863811.USD","LU1035775433.USD","LU1988902786.USD","LLYX","LU2756315664.SGD","LU1720051017.SGD","SGXZ57979304.SGD","IE00B2B36J28.USD","LU2023250330.USD","IE00BFSS7M15.SGD","LU2417539215.USD","LU0320765059.SGD","LU2750360997.AUD","LU2324357040.USD","SG9999013999.USD","LU1323610961.USD","LU0158827781.USD","LU2361045086.USD","LU1629891620.HKD","GB00BDT5M118.USD","SGXZ51526630.SGD","LU2602419157.SGD","BK4539","SG9999014906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645815172","title":"Sector Update: Healthcare Stocks Rise Pre-Bell Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2645815172","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645815172?lang=en_us&edition=fundamental","pubTime":"2026-06-24 21:22","pubTimestamp":1782307358,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  0.07% higher and the iShares Biotechnology ETF  flat.Absci  stock was up more than 28% after the company priced its underwritten offering of 13.5 million shares at $7.41 each, expecting to raise $100 million in gross proceeds. The financing includes participation from Eli Lilly , Absci said.Natera  shares were up more than 3% after the company said it has secured regulatory clearance from Japan's Pharmaceuticals and Medical Devices Agency for its Signatera molecular residual disease, or MRD, test for use in patients with colorectal cancer.ADC Therapeutics  stock was down more than 2% after the company said it will reduce its global workforce by about 17% as it shifts resources toward the Zynlonta franchise and seeks operational efficiencies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B775H168.HKD","LU2237443622.USD","BK4516","SG9999015952.SGD","LU2265009873.SGD","LU2471134796.USD","LU0012050646.USD","BK4121","LU0097036916.USD","IE0001KFT4U8.USD","LU2462157665.USD","LU0466842654.USD","LU2746668974.SGD","SG9999013999.USD","LU1323610961.USD","LU2237443895.HKD","IE0004445239.USD","LU1974910355.USD","LU1868837136.USD","LU1093756168.USD","LU2552382058.USD","LU0006306889.USD","LU0106261612.USD","LU2063271972.USD","SG9999014914.USD","LU0820562030.AUD","LU2065171402.SGD","LU0456855351.SGD","LU2756315318.SGD","LU1267930730.SGD","LU0672654240.SGD","LU1069344957.HKD","LU1989771016.USD","LU1145028129.USD","LU2023250504.SGD","LU2361044949.HKD","LU1057294990.SGD","LU0109394709.USD","LU0234572021.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2602419157.SGD","LU2211815571.USD","LU0266013472.USD","LU0823434583.USD","IE00B4R5TH58.HKD","LU2168564222.USD","LU0256863811.USD","LU0432979614.USD","LU2750360997.AUD","LU0158827781.USD","LU0786609619.USD","LU1366192091.USD","LU2237443465.HKD","IE00BKDWB100.SGD","GB00BDT5M118.USD","IE0009355771.USD","LLII","LU0345770993.USD","LU0353189763.USD","LU2237438978.USD","LU1035775433.USD","LU1548497426.USD","LU1868837300.USD","LU2361044865.SGD","IE00BKPKM429.USD","SGXZ31699556.SGD","LU1804176565.USD","LU2237443549.SGD","LU2756315664.SGD","LU0354030511.USD","LU0225283273.USD","LU0320765059.SGD","LLYZ","LU2112291526.USD","LU2471134879.HKD","SG9999017495.SGD","LU1868836757.USD","LU1629891620.HKD","IE00BK4W5M84.HKD","ELIS","LU0106261372.USD","LU2237443382.USD","LU2065731478.USD","LU0640476718.USD","LU0385154629.USD","SG9999001176.USD","SG9999014898.SGD","IE00BN29S564.USD","LU2896262040.SGD","LU0708995401.HKD","LU2491049909.HKD","LU0114720955.EUR","LU0683600562.USD","LU0053671581.USD","LU0061475181.USD","LU0820561818.USD","IE0004445015.USD","LU2023250330.USD","LU0094547139.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1868836591.USD","LU2271345857.HKD","LU1291159041.SGD","LU2028103732.USD","LU2168564495.EUR","LU0256863902.USD","XLV","LU0133085943.USD","LU2361045086.USD","IBB","LU0158827948.USD","LU0354030438.USD","LU2468319806.SGD","SG9999018857.SGD","LU2065171311.SGD","LU0471298777.SGD","LU2750360641.GBP","LU2065169927.USD","LU0820561909.HKD","LU1551013342.USD","ELIL","IE00BJLML261.HKD","ADCT","LU2746668461.USD","LU0823416689.USD","LU0882574139.USD","LU2236285917.USD","LU2471134952.CNY","LLY","IE00B7KXQ091.USD","LU0689472784.USD","LU1917777945.USD","LU0238689110.USD","LU0320765992.SGD","LU2264538146.SGD","LU2089284900.SGD","BK4533","LU2089283258.USD","BK4585","IE00B4JS1V06.HKD","LU1127390331.HKD","SG9999015945.SGD","LU2168564065.EUR","LU0417517546.SGD","LU0943347566.SGD","LU2108987350.USD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU2417539215.USD","IE00BJJMRY28.SGD","LU0353189680.USD","LU1551013425.SGD","LU2491050154.USD","SGXZ81514606.USD","LU1093756325.SGD","LU1720051108.HKD","IE00BWXC8680.SGD","LU2168563687.JPY","LU2065170008.USD","BK4139","LU2324357040.USD","LU0210536198.USD","SG9999018865.SGD","LU1064131342.USD","LU1623119135.USD","LU0122379950.USD","LU1712237335.SGD","LLYX","LU0963586101.USD","LU1280957306.USD","LU1720051017.SGD","LU2213496289.HKD","LU2471134523.USD","IE00BFSS7M15.SGD","LU0289739699.SGD","IE00BK4W5L77.USD","IE00BJJMRZ35.SGD","LU2552382215.SGD","LU0096364046.USD","SG9999014906.USD","SG9999015986.USD","LU0109391861.USD","IE00B1XK9C88.USD","LU1814569148.SGD","LU0345770308.USD","LU0889565916.HKD","SGXZ57979304.SGD","LU0079474960.USD","LU1983299246.USD","SGXZ51526630.SGD","LU2106854487.HKD","BK4007","SG9999014880.SGD","BK4588","LU2360106947.USD","LU1023059063.AUD","LU0323591593.USD","NTRA","IE0005OL40V9.USD","LU0787776722.HKD","LU2023251221.USD","SG9999015978.USD","LU2552382132.HKD","LU1988902786.USD","SGXZ99366536.SGD","LU0823434740.USD","LU2456880835.USD","IE00BJT1NW94.SGD","IE00BJJMRX11.SGD","LU0203201768.USD","LABU","LU0964807845.USD","ABSI","BK4581","BK4505","LU2237443978.SGD","LU1232071149.USD","LU2111349929.HKD","BK4539","LU0203202063.USD","LU0882574055.USD","LU2357305700.SGD","LU2461242641.AUD","BK4599","LU2089984988.USD","LU0471298694.HKD","LU2087625088.SGD","XBI","IE0002141913.USD","LU2491050071.SGD","SG9999001176.SGD","IE00B1BXHZ80.USD","LU0058720904.USD","LU0316494557.USD","LU2168564149.EUR","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645792897","title":"U.S. Stocks on the Move-take-two, Wendy's, Absci","url":"https://stock-news.laohu8.com/highlight/detail?id=2645792897","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645792897?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:38","pubTimestamp":1782301106,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Take-Two, Wendy's, AbsciWorkspace search string for individual stock moves:STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL6N42W0QD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054578231.USD","LU0496367417.USD","LU0303821028.USD","LU1815336091.USD","BK4504","FLS","LU1430597077.USD","LU0266512473.USD","BK4131","FDX","BK4141","LU1223082196.USD","BK4121","LU1023059493.AUD","IE00B19Z3581.USD","BK4085","LU1883866441.USD","CCXI","LU0170899867.USD","LU2229751404.USD","LU0048573561.USD","BK4161","BK4510","BK4539","BK4509","BK4524","IE00B19Z3B42.SGD","LU0719512351.SGD","BK4139","LU0654597011.USD","LU1102505762.USD","LU0788108826.HKD","LU0143863198.USD","BK4547","BK4554","09626","LU2089279066.USD","IE0002270589.USD","LU0630314457.HKD","LU0162691827.USD","LU0303823156.USD","BK4017","WEN","LU2360107168.USD","NEM","LU0082616367.USD","BK4566","LU0498741114.HKD","LU0143863784.USD","LU0061475181.USD","LU1267930227.SGD","LU0278409577.USD","LU0251131958.USD","LU1223082519.USD","LU2498475776.HKD","BK4548","LU0128525689.USD","AU","LU0300736062.USD","LU1868838027.USD","BK4585","LU0345780281.USD","BK4532","LU1102505929.USD","CBRS","BK4533","LU1868837565.USD","LU0300736492.USD","LU1861220033.SGD","BK4505","LU0310800965.SGD","BK4209","LU0055631609.USD","LU0498741890.SGD","LU1280957306.USD","BK4577","BK4563","GFI","BK4531","BK4570","LU0075056555.USD","NWMX","NEMG","HMY","ABSI","LU0368265764.SGD","BILI","LU0612318971.USD","LU0345780950.USD","LU0724618789.USD","LU0072461881.USD","LU0006061336.USD","LU0456854461.SGD","LU0052756011.USD","LU2462611646.USD","LU1323610961.USD","LU0345781412.USD","BK4503","BK4588","BK4526","LU0266512127.USD","LU1861215975.USD","BK4077","LU0612318385.USD","BK4513","LU1223083913.SGD","TTWO","SG9999001143.SGD","BK4522","LU1571399168.USD","LU2290526834.HKD","LU0251142724.SGD","LU0081259029.USD","LU0788109121.HKD","LU0330918003.SGD","LU0640476718.USD","LU0757428866.USD","LU0345780521.USD","LU0742534661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645869897","title":"Absci Rises on Positive Hair-loss Drug Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2645869897","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645869897?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:11","pubTimestamp":1782299478,"startTime":"0","endTime":"0","summary":"BUZZ-Absci rises on positive hair-loss drug data** Shares of drug developer AbsciABSI.Orise 17.9% to $8.74 premarket** Coreports datafrom an early-stage trial of ABS-201, its experimental drug developedusing AI, targeting androgenetic alopecia, a common form of hair loss** Co says early data from 32 healthy adults who received a single dose showed the drug appeared well tolerated, with no serious side effects reported as of June 8** Data suggests ABS-201 had an estimated half-life of at least 65 days, supporting the potential for two or three injections over a six-month period** Co plans to begin a mid-stage study of ABS-201 for endometriosis later this year** Separately, Absci prices a $100 million stock offering backed by Eli LillyLLY.Nand several investment firms,and plans to use the proceedsto fund development of ABS-201 in pattern hair loss and endometriosis** As of last close, ABSI stock more than doubled YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nL6N42W0P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","BK4539","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645044894","title":"Absci Corp Shares up 14% Premarket After Co Reports Early-stage Trial Data from Its Ai-designed Hair Loss Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2645044894","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645044894?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:43","pubTimestamp":1782297783,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42V17V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4139","BK4539","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894058","title":"Absci prices 13.5M shares at $7.41 in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894058","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894058?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:40","pubTimestamp":1782297614,"startTime":"0","endTime":"0","summary":"Absci (ABSI) announced the pricing of an underwritten offering of 13,495,277 shares of its common stock at a price of $7.41 per share, before deduc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-prices-13-5m-shares-at-7-41-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-prices-13-5m-shares-at-7-41-in-public-offering-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4121","BK4539","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645089409","title":"Absci reports Phase 1 data from human trial of ABS-201","url":"https://stock-news.laohu8.com/highlight/detail?id=2645089409","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645089409?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:35","pubTimestamp":1782297324,"startTime":"0","endTime":"0","summary":"Absci (ABSI) reported positive interim Phase 1 data from its first-in-human trial of ABS-201, an investigational anti-prolactin receptor, or PRLR, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/absci-reports-phase-1-data-from-human-trial-of-abs-201-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/absci-reports-phase-1-data-from-human-trial-of-abs-201-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4121","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645489420","title":"Absci Prices 13,495,277-share Follow-on Offering at $7.41 Per Share to Raise $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2645489420","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645489420?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:35","pubTimestamp":1782297318,"startTime":"0","endTime":"0","summary":"Absci prices 13,495,277-share follow-on offering at $7.41 per share to raise $100 millionAbsci priced an underwritten follow-on offering of 13,495,277 common shares at USD 7.41 per share.Gross proceed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL4RmZ68:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABSI","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645942608","title":"Absci Corp - Prices Underwritten Offering of 13.5 Mln Shares at $7.41 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2645942608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645942608?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:35","pubTimestamp":1782297300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA3HNQQ0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4121","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894032","title":"Absci Corp - Eli Lilly & Company and Others Participate in $100 Mln Absci Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894032","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894032?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:35","pubTimestamp":1782297300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA3HNQQ0:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443622.USD","LU0820561909.HKD","IE00BK4W5M84.HKD","SG9999014898.SGD","SG9999014914.USD","SGXZ31699556.SGD","BK4539","LU2106854487.HKD","SGXZ57979304.SGD","LU0133085943.USD","IE00B2B36J28.USD","LU2211815571.USD","LU0823434583.USD","LU2491050071.SGD","IE00BJJMRX11.SGD","LU2462157665.USD","LU2471134879.HKD","LU1061106388.HKD","IE00BK4W5L77.USD","LLYZ","LU2461242641.AUD","SGXZ99366536.SGD","LU0471298694.HKD","BK4599","LU1291159041.SGD","LU2491049909.HKD","IE00BJLML261.HKD","LU1093756168.USD","LU1974910355.USD","LU2417539215.USD","LU2471134523.USD","IE0002141913.USD","ABSI","LU1983299246.USD","LU2108987350.USD","LU2237438978.USD","LU2237443382.USD","LU2361045086.USD","SGXZ51526630.SGD","LU1712237335.SGD","LU0353189763.USD","IE0001KFT4U8.USD","LU0787776722.HKD","LU0256863902.USD","LU2324357040.USD","SG9999015978.USD","IE00BJJMRZ35.SGD","BK4516","IE0009355771.USD","LU1868836591.USD","ELIL","LU1232071149.USD","LU2087625088.SGD","LU2552382132.HKD","LU2746668974.SGD","LU0109394709.USD","BK4585","SG9999013999.USD","LU1548497426.USD","LU0823416689.USD","LU2023250330.USD","LU1868837300.USD","LU2361044865.SGD","SG9999014880.SGD","LU0964807845.USD","LU0456855351.SGD","LU0820562030.AUD","LU0289739699.SGD","LU2468319806.SGD","LU2112291526.USD","LU2756315664.SGD","LU0417517546.SGD","LU0323591593.USD","LU0882574139.USD","LU0432979614.USD","LU1814569148.SGD","IE00B7KXQ091.USD","LU2750360997.AUD","IE0004445015.USD","IE00BWXC8680.SGD","LU0006306889.USD","GB00BDT5M118.USD","LU2456880835.USD","SG9999001176.USD","LU0256863811.USD","LU0203201768.USD","SG9999001176.SGD","IE00B1BXHZ80.USD","IE00BFSS8Q28.SGD","IE00B775H168.HKD","LU1323610961.USD","LU0058720904.USD","LU2236285917.USD","LU0097036916.USD","LU0266013472.USD","LU0122379950.USD","LU0823434740.USD","LU1868836914.USD","LU0158827781.USD","LU0889565916.HKD","LU1917777945.USD","BK4588","LU1069344957.HKD","LU1267930730.SGD","LU1720051108.HKD","LU0353189680.USD","LU1057294990.SGD","LU0708995401.HKD","LU1868836757.USD","LU2028103732.USD","LU2089284900.SGD","LU2168564149.EUR","LU0820561818.USD","LU0109391861.USD","LU2168563687.JPY","LU2063271972.USD","LU0106261372.USD","LU1551013425.SGD","IE00BKDWB100.SGD","LU2491050154.USD","LU0158827948.USD","LU2361044949.HKD","LU2111349929.HKD","LU2237443978.SGD","BK4139","LU2023250504.SGD","LU2756315318.SGD","LU2471134952.CNY","SG9999014906.USD","LU0466842654.USD","IE00BKPKM429.USD","LU0079474960.USD","LU0234572021.USD","LU2213496289.HKD","SG9999018857.SGD","LU1280957306.USD","LU0354030438.USD","LU1989771016.USD","LU2360106947.USD","LU0385154629.USD","IE00B4JS1V06.HKD","IE00BJJMRY28.SGD","LLII","LU1551013342.USD","LU2168564495.EUR","IE0005OL40V9.USD","LU0689472784.USD","LU1127390331.HKD","SG9999015986.USD","IE00B4R5TH58.HKD","LU2237443895.HKD","LU0672654240.SGD","BK4007","LU0683600562.USD","IE00BFTCPJ56.SGD","BK4533","IE00BJT1NW94.SGD","LU0094547139.USD","LU2237443465.HKD","IE00B1XK9C88.USD","LU1720051017.SGD","LU2089283258.USD","LU0210536198.USD","LU2023251221.USD","LU1623119135.USD","LU2271345857.HKD","LU0061475181.USD","SG9999017495.SGD","BK4534","IE00BFSS7M15.SGD","LU2552382215.SGD","LU1064131342.USD","IE0004445239.USD","LU1366192091.USD","LU1988902786.USD","ELIS","LU0786609619.USD","LU1023059063.AUD","LU1035775433.USD","LU2264538146.SGD","LU0238689110.USD","LU0320765059.SGD","LU2357305700.SGD","LU1093756325.SGD","LU0225283273.USD","LU2750360641.GBP","LU0198837287.USD","SG9999015952.SGD","LU2552382058.USD","LU0471298777.SGD","LU2896262040.SGD","LU2237443549.SGD","LLY","LU0096364046.USD","LU0882574055.USD","LLYX","LU1145028129.USD","LU1804176565.USD","LU2265009873.SGD","LU0354030511.USD","IE00BN29S564.USD","LU2168564222.USD","LU0320765992.SGD","SG9999015945.SGD","LU1629891620.HKD","SG9999018865.SGD","LU0943347566.SGD","LU0114720955.EUR","LU2602419157.SGD","SGXZ81514606.USD","LU2168564065.EUR","LU1868837136.USD","BK4121","BK4581","LU0640476718.USD","LU2089984988.USD","LU2746668461.USD","LU0316494557.USD","LU2471134796.USD","LU0203202063.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645489449","title":"Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2645489449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645489449?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:35","pubTimestamp":1782297300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA3HNQQ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4121","BK4139","ABSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645894433","title":"Absci Reports Positive Interim Phase 1 Data for Abs-201 Antibody in Headline Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2645894433","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645894433?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:30","pubTimestamp":1782297053,"startTime":"0","endTime":"0","summary":"Absci reports positive interim Phase 1 data for ABS-201 antibody in HEADLINE trialAbsci reported positive interim Phase 1 data for ABS-201, its first-in-human antibody targeting the prolactin receptor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL2Mvfvb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABSI","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","BK4588","IE00BGHQF748.EUR","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","BK4139","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4121","IE00B3QW5Z07.USD","SG9999014039.USD","NDAQ","SG9999014021.USD","LU2210150020.SGD","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645989413","title":"Absci Corp - Abs-201 Half-life Estimated at Least 65 Days Supports Infrequent Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2645989413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645989413?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:30","pubTimestamp":1782297000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA5JPKDS:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ABSI","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645941338","title":"Absci Corp - Abs-201 Well Tolerated with Favorable Safety Data in All Sad Cohorts","url":"https://stock-news.laohu8.com/highlight/detail?id=2645941338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645941338?lang=en_us&edition=fundamental","pubTime":"2026-06-24 18:30","pubTimestamp":1782297000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nTUA5JPKDS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABSI","BK4139","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.absci.com;investors.absci.com","stockEarnings":[{"period":"1week","weight":0.3779},{"period":"1month","weight":0.9337},{"period":"3month","weight":2.6727},{"period":"6month","weight":1.8599},{"period":"1year","weight":2.6993},{"period":"ytd","weight":1.9255}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":-0.0217},{"period":"3month","weight":0.158},{"period":"6month","weight":0.0637},{"period":"1year","weight":0.2095},{"period":"ytd","weight":0.0768}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; with AstraZeneca PLC for AI-driven drug discovery against an oncology target; and with Twist Bioscience Corporation to design a novel therapeutic using generative AI. The company was founded in 2011 and is headquartered in Vancouver, Washington.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.106318},{"month":2,"riseRate":0.6,"avgChangeRate":0.064917},{"month":3,"riseRate":0.4,"avgChangeRate":-0.085447},{"month":4,"riseRate":0.4,"avgChangeRate":0.03426},{"month":5,"riseRate":0.4,"avgChangeRate":0.033031},{"month":6,"riseRate":0.2,"avgChangeRate":-0.015283},{"month":7,"riseRate":0.75,"avgChangeRate":0.242017},{"month":8,"riseRate":0.2,"avgChangeRate":-0.131623},{"month":9,"riseRate":0.2,"avgChangeRate":-0.114873},{"month":10,"riseRate":0.8,"avgChangeRate":0.133791},{"month":11,"riseRate":0.2,"avgChangeRate":-0.134033},{"month":12,"riseRate":0.4,"avgChangeRate":0.218437}],"exchange":"NASDAQ","name":"Absci Corporation.","nameEN":"Absci Corporation."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Absci Corporation.,ABSI,Absci Corporation.股票,Absci Corporation.股票老虎,Absci Corporation.股票老虎国际,Absci Corporation.行情,Absci Corporation.股票行情,Absci Corporation.股价,Absci Corporation.股市,Absci Corporation.股票价格,Absci Corporation.股票交易,Absci Corporation.股票购买,Absci Corporation.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Absci Corporation.(ABSI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Absci Corporation.(ABSI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction